Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesBiological mechanisms of bevacizumab-associated adverse events
Expert Review of Anticancer Therapy, 07/15/09
Higa GM et al. - Although the benefits demonstrated in clinical trials led to the approval of bevacizumab for treatment of colorectal, lung and breast cancers, and most recently glioblastoma, a number of serious soft-tissue and vascular toxicities have also been observed in patients receiving this anti-angiogenic agent. This review assesses the relationship between inhibition of VEGF and toxicity, and proposes the pathogenic mechanisms that lead to the adverse events.
Related Articles
Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
Current Medical Research and Opinion, 10/30/09
Relevance Score: 71%
Nurse Reports of Adverse Events During Sedation Procedures at a Pediatric Hospital
Journal of PeriAnesthesia Nursing, 11/03/09
Relevance Score: 69%
Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm
Current Medical Research and Opinion, 11/17/09
Relevance Score: 68%
The witching time: diurnal patterns in adverse events of clinical management
Clinical Governance: An International Journal, 10/29/09
Relevance Score: 68%
Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Reviews, 10/13/09
Relevance Score: 68%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies
Expert Opinion in Pharmacotherapy, 12/11/09
Zoledronic acid: an unending tale for an antiresorptive agent
Expert Opinion in Pharmacotherapy, 12/11/09
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
British Journal of Cancer, 12/11/09
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Effects of functional electrical stimulation on dysphagia caused by radiation therapy in patients with nasopharyngeal carcinoma
Supportive Care in Cancer, 12/09/09
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor